Rapid7 is trading at $11.77, down 5.16%, after no clearly reported September 18, 2026 company-specific catalyst emerged.
- Recent coverage highlights JPMorgan’s September 15 downgrade to Underweight with a $12 target, citing transition concerns.
- Management expects core growth roughly flat through 2027.
- Broader indexes are only modestly lower, so market sentiment alone does not clearly explain the decline.